Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Novarella

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of the Neurological Sciences|December 7, 2025
Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosisValerio Nicolella, Marco Varelli, Stefania Fasano, et al.
Neurology International|September 26, 2025
Plasma Neurofilament Light Chain Is Associated with Cognitive Functions but Not Patient-Reported Outcomes in Multiple SclerosisValerio Nicolella, Federica Novarella, Fabrizia Falco, et al.
Journal of Neurology|August 23, 2024
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimodAntonio Carotenuto, Cristina Di Monaco, Laura Papetti, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of the Neurological Sciences|December 7, 2025
Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosisValerio Nicolella, Marco Varelli, Stefania Fasano, et al.
Neurology International|September 26, 2025
Plasma Neurofilament Light Chain Is Associated with Cognitive Functions but Not Patient-Reported Outcomes in Multiple SclerosisValerio Nicolella, Federica Novarella, Fabrizia Falco, et al.
Journal of Neurology|August 23, 2024
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimodAntonio Carotenuto, Cristina Di Monaco, Laura Papetti, et al.
Pageof 2